Precision BioSciences, Inc.
DTIL
$6.30
$0.6311.11%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -45.72M | -83.60M | -78.26M | -21.99M | 7.17M |
| Total Depreciation and Amortization | 2.75M | 2.83M | 3.17M | 3.86M | 4.58M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.37M | 8.62M | 4.28M | -5.42M | -16.19M |
| Change in Net Operating Assets | -29.24M | -1.13M | 6.88M | -34.97M | -54.00M |
| Cash from Operations | -65.84M | -73.28M | -63.92M | -58.52M | -58.45M |
| Capital Expenditure | -85.00K | -163.00K | -202.00K | -228.00K | -250.00K |
| Sale of Property, Plant, and Equipment | 66.00K | 22.00K | 5.00K | 0.00 | 60.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -615.00K | -265.00K | -290.00K | -275.00K | -25.00K |
| Cash from Investing | -634.00K | -406.00K | -487.00K | -503.00K | -215.00K |
| Total Debt Issued | -- | -20.00K | 22.47M | 22.47M | 22.47M |
| Total Debt Repaid | -- | 0.00 | -22.51M | -22.51M | -22.51M |
| Issuance of Common Stock | 95.16M | 23.59M | 25.68M | 21.08M | 50.49M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 95.16M | 23.57M | 25.64M | 21.04M | 50.45M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 28.69M | -50.12M | -38.77M | -37.98M | -8.21M |